# Faz 7.1 — Commercialization Readiness Gate (Deferred Placeholder)

## 1. Context

`Main-Planing.md` Section 6, Phase 7 description: "Not started now, per the user's explicit answer during intake ('şu anlık kendim o konu hakkında düşünmüyorum' — 'I'm not currently thinking about that topic myself'). Kept as a placeholder so future work has a clear on-ramp." `Main-Planing.md` Section 9 (Step 2 Preparation Notes) is unambiguous: "Phase 7 (Commercialization Readiness Gate) must not receive detailed sub-planning until the user explicitly signals commercialization intent is becoming concrete — expanding it now would be speculative planning against the user's own stated position." This sub-plan exists **only** to satisfy the Second-Planner's structural requirement that every main phase have a corresponding folder and at least one sub-plan file (Coverage Check, Section 6 of the Sub-Planing-Index requirements) — it is deliberately written at minimal, non-speculative depth, consistent with the Second-Planner's own instruction: "If a phase is future/uncertain, plan it at a lower detail level and explicitly mark unresolved decisions."

## 2. Goal

Preserve a clear, low-cost on-ramp for future commercialization planning, without performing any of that planning now — respecting the user's explicit, currently-stated position that commercialization is not something they are actively considering.

## 3. Description

**Why this sub-phase is intentionally minimal:** Unlike every other sub-plan in this roadmap, this one does not decompose real work. `Autopsy.md` and `Main-Planing.md` both independently confirm the user was asked directly during Step 1 intake and gave an explicit non-commitment answer. Detailed planning here — licensing strategy, ToS/privacy policy drafting, RLS/anon-key exposure redesign, fingerprinting privacy review — would be planning against evidence the user themselves provided, which the vibecoding principles explicitly warn against ("say when evidence is weak instead of creating fake certainty" and "preserve room for discovery... instead of over-specifying every implementation detail too early" apply doubly here, since the *timing* itself, not just the details, is unconfirmed).

**What this sub-phase does instead:** It records the specific, concrete questions that *would* need answering if/when commercialization becomes concrete, sourced directly from `Main-Planing.md` and `Autopsy.md`'s own forward-looking notes, so that a future ClaudeQB Step 2 replanning session (triggered by the user, not by this session) has a starting point rather than a blank page.

**Vibecoding slice strategy:** The entire "slice" here is: do nothing now, but leave a clear, evidence-sourced list of open questions for later. This is the correct vibecoding-first response to an explicitly out-of-scope-for-now phase — not silence (which would lose the context), and not detailed planning (which would be speculative).

## 4. Scope

- Recording the specific commercialization-adjacent open questions already identified elsewhere in this Planner-docs set, so they are not lost:
  - Licensing terms, Terms of Service, and privacy policy — currently entirely undefined (`Main-Planing.md` Section 4: "Commercialization-specific requirements ... are explicitly not yet defined by the user").
  - The Supabase RLS/anon-key exposure model's appropriateness "for a paid or wider-distribution product" (`Main-Planing.md` Section 6, Phase 7 description).
  - Whether the community `sync_presets` fingerprinting scheme (browser fingerprint hash for vote deduplication, per `Autopsy.md` Section 9: `useCloudSync.ts:99-101`) has privacy implications "at commercial scale" that it does not have at the current low-traffic, personal-tool scale.
- Recording the explicit trigger condition for expanding this phase: the user directly signaling commercialization intent is becoming concrete (not merely being asked about it again by a routine planning cycle).

## 5. Out of Scope

- Everything else. No licensing strategy, no ToS/privacy-policy drafting, no RLS redesign, no fingerprinting-privacy remediation, no payment/legal-structure planning. All of it is explicitly deferred, per both `Main-Planing.md` Section 4 and Section 6, and per the ClaudeQB Second-Planner's own instruction not to expand phases the Main Plan marks as not-yet-signaled.

## 6. Current Repository Evidence

Current repository evidence is limited for this sub-phase by design — this sub-phase does not perform new repository analysis, since doing so would itself be a step toward the detailed planning this sub-plan is structurally prevented from doing. The questions recorded in Section 4 are sourced entirely from `Main-Planing.md` Sections 4, 6, and `Autopsy.md` Section 9, all already gathered during Step 1/Step 1.5 of this ClaudeQB run.

- `Main-Planing.md` Section 4 — "Commercialization-specific requirements (licensing terms, ToS, privacy policy, payment/legal structure) are explicitly not yet defined by the user and are treated as a deferred, gated phase (see Phase 7) rather than a current target."
- `Main-Planing.md` Section 6, Phase 7 — the three named future questions (license/ToS/privacy review, RLS/anon-key exposure model, fingerprinting privacy implications).
- `Autopsy.md` Section 9 — "This is currently low-risk for a niche personal-use tool but becomes a real gap the moment commercialization (Phase 7, deferred) is pursued," regarding the `sync_presets` fingerprint-hash-for-vote-deduplication scheme.

## 7. Planned Work Breakdown

This sub-phase has no execution work breakdown in the FX.Y-NN sense the other sub-plans in this roadmap use, since it performs no implementation, design, or detailed decomposition. Its only "work item" is the one already completed by writing this file:

- **F7.1-01 — Preserve the deferred-question list**
  - Description: Record the three specific commercialization-adjacent open questions (license/ToS/privacy, RLS/anon-key exposure, fingerprinting privacy at scale) as a durable reference for future replanning, sourced from existing Main Plan and Autopsy evidence, with no new analysis performed.
  - Output: This sub-plan document itself.

## 8. Acceptance Criteria

- This sub-plan exists, satisfying the structural requirement that every main phase has at least one sub-plan file.
- No licensing, ToS, privacy-policy, RLS-redesign, or fingerprinting-remediation work is performed as part of this sub-phase.
- The three deferred questions from Section 4 are recorded accurately, sourced from existing Main Plan/Autopsy evidence, not invented.
- The explicit trigger condition for expanding this phase (direct user signal) is stated clearly.
- Step 3's audit should treat any Step 4 execution attempt against this sub-plan beyond "confirm the phase is still correctly deferred" as a scope violation, since this sub-plan authorizes no implementation work.

## 9. Validation and Test Approach

- **Validation is structural, not functional:** confirming this file exists with the required section structure (VAL-DOCS-STRUCTURE) is the only applicable check — there is no code, command, or live behavior to validate, since no implementation is planned or authorized.
- No local, live, security, or CI validation applies to this sub-phase's content.

```markdown
| Path | State | Purpose | Validation Command IDs |
|---|---|---|---|
| Planner-docs/Faz-7-Plans/Faz7.1-commercialization-gate-deferred.md | proposed | This document itself — a deliberately minimal placeholder preserving deferred commercialization questions for future replanning. | VAL-DOCS-STRUCTURE |
```

## 10. Dependencies and Sequencing

- Depends on nothing; blocks nothing. This sub-phase has no execution dependency on any other phase, and no other phase depends on it.
- Requires no credentials, live endpoints, infrastructure, or human approval to exist as a placeholder.
- **Requires explicit human approval before ever being expanded** — this is the one sub-plan in the entire roadmap where the default action is "do not proceed" rather than "proceed once dependencies are met."
- Fresh Claude Code session token/context risk: **Unknown — deferred**, per `Main-Planing.md` Section 6's own roadmap table entry for Phase 7. No subagent is relevant since no work is being planned.

## 11. Risks and Mitigations

- **Risk:** A future Step 2 or Step 4 session, seeing a "Phase 7" folder and file, assumes it is safe to expand or implement without re-checking whether the user has actually signaled commercialization intent.
  - Impact: Speculative work performed against the user's own explicitly stated non-intent, wasting effort and potentially creating premature legal/compliance artifacts (e.g., a ToS draft) that do not reflect an actual, considered business decision.
  - Mitigation: This document's Section 3, Section 5, and Section 10 all explicitly and repeatedly state that expansion requires a new, explicit user signal — not silence, not the mere passage of time, not a routine replanning cycle noticing this phase is "still empty."
- **Risk:** The deferred-question list in Section 4 becomes stale or incomplete if new commercialization-adjacent concerns are discovered in later phases (e.g., Phase 6's operational work) without being added here.
  - Impact: Future replanning starts from an incomplete question list.
  - Mitigation: Any future sub-phase that surfaces a new commercialization-relevant concern should note it in `Planing-Ledger.md`'s Open Decisions section (per the ledger's own purpose), which this Faz7.1 placeholder should be cross-referenced against when the phase is eventually actually expanded.

## 12. Desired End State

Phase 7 remains a structurally complete but intentionally unexpanded placeholder: a folder and one minimal sub-plan exist, satisfying ClaudeQB's coverage requirements, while zero commercialization-specific implementation, design, or detailed planning work has been performed. The moment the user explicitly signals commercialization intent is becoming concrete, a future ClaudeQB Step 2 session has a ready-made, evidence-sourced starting question list rather than having to reconstruct it from scattered references across the rest of Planner-docs.

## 13. Next Sub-Phase Transition Criteria

- There is no "next sub-phase" within Phase 7 to transition to under current conditions — this is Phase 7's only sub-plan, and it should remain Phase 7's only sub-plan until the explicit trigger condition (direct user signal of commercializing intent) is met.
- When that trigger occurs, the appropriate action is a **new ClaudeQB Step 1.5/Step 2 replanning cycle** scoped specifically to Phase 7 — not a silent expansion of this placeholder file — so that the expansion itself goes through the same evidence-gathering discipline every other phase in this roadmap received.
